Calio', Anna
 Distribuzione geografica
Continente #
EU - Europa 2.118
NA - Nord America 1.965
AS - Asia 822
OC - Oceania 7
AF - Africa 6
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.925
Nazione #
US - Stati Uniti d'America 1.960
GB - Regno Unito 766
CN - Cina 606
IT - Italia 269
SE - Svezia 251
IE - Irlanda 214
FR - Francia 174
RU - Federazione Russa 155
SG - Singapore 134
DE - Germania 124
FI - Finlandia 79
UA - Ucraina 37
BE - Belgio 23
JP - Giappone 15
KR - Corea 14
HK - Hong Kong 13
VN - Vietnam 11
AU - Australia 6
TR - Turchia 6
IR - Iran 5
CA - Canada 4
IN - India 4
PL - Polonia 4
AR - Argentina 3
CZ - Repubblica Ceca 3
MA - Marocco 3
MK - Macedonia 3
NL - Olanda 3
AT - Austria 2
CM - Camerun 2
ES - Italia 2
HU - Ungheria 2
LV - Lettonia 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
Totale 4.925
Città #
Southend 721
Chandler 423
Dublin 212
Woodbridge 171
Jacksonville 151
Ann Arbor 138
Beijing 134
Ashburn 127
Singapore 94
Lawrence 69
Princeton 69
Wilmington 67
Jinan 60
Verona 57
Houston 55
New York 51
Shenyang 48
Redmond 42
Hebei 37
Helsinki 33
Nanjing 33
Sindelfingen 31
Tianjin 27
Ningbo 26
Bologna 24
Changsha 23
Hangzhou 22
Redwood City 22
Seattle 22
Brussels 18
Milan 18
Taizhou 18
Lancaster 17
Zhengzhou 16
Nanchang 14
Seoul 14
Taiyuan 13
Dallas 11
Dearborn 11
Tokyo 11
Fairfield 10
Guangzhou 10
Haikou 10
Norwalk 10
Boardman 9
Hong Kong 9
Pozza 9
Washington 8
Dong Ket 7
Falls Church 7
Fuzhou 7
Jiaxing 7
San Donà Di Piave 7
Bergamo 6
Kent 6
Boydton 5
Düsseldorf 5
Lappeenranta 5
Rome 5
San Francisco 5
Augusta 4
Berlin 4
Cagliari 4
Chicago 4
Los Angeles 4
Lozzo Atestino 4
Munich 4
Paese 4
Perugia 4
Ardabil 3
Auburn Hills 3
Brno 3
Buenos Aires 3
Cambridge 3
Detroit 3
Isola della Scala 3
Kochi 3
Lanzhou 3
Lonigo 3
Moscow 3
Phoenix 3
Prilep 3
Rio Saliceto 3
Toronto 3
Amsterdam 2
Cementon 2
Dongguan 2
Durham 2
Fremont 2
Genova 2
Leawood 2
Mainz 2
Manila 2
Melbourne 2
Monmouth Junction 2
Negrar 2
Osaka 2
Palermo 2
Rabat 2
Riga 2
Totale 3.410
Nome #
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 148
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 124
Pancolitis with ischemic injury as a complication of immunosuppressive treatment in a patient with autoimmune hepatitis: a case report. 122
Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis 121
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 119
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 115
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 112
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 108
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 105
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 103
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 102
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 101
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 101
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 100
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 97
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 95
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 92
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 91
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 90
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 87
Increased Frequency of Bronchiolar Histotypes in Lung Carcinomas Associated with Idiopathic Pulmonary Fibrosis 84
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 84
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation 82
Primary Seminal Vesicle Carcinoma. The Usefulness of Pax8 Immunohistochemical Expression for the Differential Diagnosis 79
Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases 77
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis 76
Cathepsin K expression in clear cell "sugar" tumor (PEComa) of the lung 71
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 71
MiT family translocation renal cell carcinoma: looking for diagnostic and druggable markers 66
Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma 64
Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer? 63
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 61
Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'? 59
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 59
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 59
High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment 58
Multifocal Hepatic Angiosarcoma with Atypical Presentation: Case Report and Literature Review 58
Renomedullary Interstitial Cell Tumors: Pathologic Features and Clinical Correlations 56
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 56
From fine-needle aspiration cytology to fluorescent in-situ hybridization in an unusual case of pharyngeal synovial sarcoma 55
Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys 55
Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens 54
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 53
A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss 51
VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations 50
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 50
Epithelioid angiomyolipoma: a pathological entity discovered in Verona with the endorsement of Doctor Rosai 49
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 48
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 48
Recurrent primary endobronchial fetal rhabdomyoma: a case report and literature review 48
Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation 47
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors 47
Mixed Epithelial and Stromal Tumor of the Kidney: A Clinicopathologic Study of 53 Cases 45
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 45
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour 44
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 44
Intestinal-type primary vaginal adenocarcinoma. Review of the literature with report of a case: from diagnosis to management 44
Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press 43
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1 41
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey 41
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification 41
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 40
Histology and immunohistochemical evaluation of phimotic prepuce: The role of steroid therapy 39
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 38
Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas 37
Pathological features and clinical associations of 58 small incidental angiomyolipomas of the kidney. 36
Papillary Adenomas and Other Small Epithelial Tumors in the Kidney: An Autopsy Study 32
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 31
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 29
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 27
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 26
2022-RA-1535-ESGO Uterine PEComa and prognostic value of the proposed classification systems: a retrospective study, systematic review, and metanalysis 23
Well-differentiated neuroendocrine tumor of the urinary bladder expressing GATA 3 22
Hot topics in renal cancer pathology: implications for clinical management 22
A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022) 22
Multitarget Fluorescence in Situ Hybridization diagnostic applications in solid and hematological tumors 22
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma 20
HER2 Aberrations in NSCLC: So Close Yet So Far 18
Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma 15
Histology for nephrology, from pre-implantation to post-transplant kidney biopsy. Lesson learned from ReBIrth (Renal BIopsy for Kidney Transplantation Therapy) 14
WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist 14
Robot-assisted excision of hemangioma of the right renal vein 14
MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical management 14
The World Health Organization 2022 Classification of renal tumors: key updates for urologists 12
Real-world biomarker testing patterns: clinical-pathological portrait of early and late non-small cell lung cancer in hub and spoke North Italian centers 12
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy 12
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data 10
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives 10
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 10
Patient Selection for Active Surveillance for Small Renal Masses: A Systematic Review of the Literature 9
Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations 9
Small renal masses in young adults: Insights from a large contemporary multi-institutional Registry 8
SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal Bone Biopsy Procedure: BOP) 8
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 7
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe 7
Oncocytoma on renal mass biopsy: why is surgery even performed? 7
Uterine perivascular epithelioid cell tumors (PEComa) and the accuracy of proposed classification systems in predicting the malignant versus non-malignant behavior 6
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 6
Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice 6
Single-port robotic partial nephrectomy: impact on perioperative outcomes and hospital stay 5
Totale 5.158
Categoria #
all - tutte 20.380
article - articoli 19.750
book - libri 0
conference - conferenze 435
curatela - curatele 0
other - altro 195
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020395 0 0 16 26 57 74 40 22 33 41 34 52
2020/2021614 72 69 34 83 75 80 29 19 18 31 68 36
2021/2022608 67 154 3 72 29 26 17 37 20 14 43 126
2022/20231.278 82 134 106 223 103 332 20 66 134 21 33 24
2023/2024793 36 58 73 73 89 128 42 54 22 48 122 48
2024/2025292 125 136 31 0 0 0 0 0 0 0 0 0
Totale 5.172